Omega Therapeutics

parachute chutes
Biotech

Roche, Vir, Neurocrine & more—Chutes & Ladders

Roche bids adieu to pharma vet Sabry. Vir fills vacant CMO spot. Neurocrine maps out CEO succession plan.
ship flagship sail ocean boats

Novo Nordisk inks obesity, MASH pacts with 2 Flagship biotechs

Jan 4, 2024 7:34am
Omega Therapeutics CEO Mahesh Karande

Omega taps Stanford to find targets for genome-tuning tech

Oct 14, 2021 9:05am
DNA

Outsmarting cancer with RNA and other gene-altering therapies

Jun 28, 2021 5:00pm
Omega Therapeutics CEO Mahesh Karande

Omega grabs $126M to bring 'genome-tuning' program into clinic

Mar 30, 2021 7:00am
Omega Therapeutics CEO Mahesh Karande

'Genome-tuning' biotech Omega Therapeutics snags $85M

Jul 29, 2020 8:00am